Trial Profile

Phase I trial of SP-104 for the treatment of chronic pain and fibromyalgia

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 06 Mar 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Naltrexone (Primary)
Indications Fibromyalgia; Pain
Focus Adverse reactions
Sponsors Scilex Pharmaceuticals

Most Recent Events

04 Mar 2024 According to the Scilex Holding Company media release,Phase 2 clinical trial is expected to commence in 2024.
19 Apr 2022 New trial record
13 Apr 2022 According to the Scilex Holding Company media release, this trial is expected to be initiated this year.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com